ADAGIO THERAPEUTICS INC (ADGI)

US00534A1025 - Common Stock

4.64  +0.04 (+0.87%)

After market: 4.52 -0.12 (-2.59%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2022-6-30)		 2021
(2021-12-31)		 2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-295.07M-226.79M-65.32M
Depreciation Amortization
N/A1.00KN/A
Change In Working Capital
27.18M22.79M10.68M
Other non cash items
24.01M19.26M40.07M
OPERATING CASH FLOW
-243.87M-184.74M-14.57M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/A-84.00KN/A
Other Investing Activity
N/A-50.63MN/A
INVESTING CASH FLOW
N/A-50.71MN/A
 
CASH FLOWS FROM FINANCING ACTIVITIES
Stock Issued/Repurchased
330.92M666.07M129.56M
Other Financing Activity
N/A-3.38MN/A
FINANCING CASH FLOW
327.97M662.68M129.56M
 
CHANGE IN CASH
82.38M427.24M114.99M
 
FREE CASH FLOW
Operating Cash Flow
-243.87M-184.74M-14.57M
Capital Expenditure
N/A-84.00KN/A
FREE CASH FLOW
N/A-184.82MN/A

All data in USD

Charts